13 August 2021 - Ticovac may help reduce the risk of tick-borne encephalitis for people traveling to endemic areas, potentially including military personnel serving in these locations.

Pfizer today announced that the U.S. FDA has approved Ticovac (tick-borne encephalitis vaccine) for active immunization to prevent tick-borne encephalitis in individuals 1 year of age and older.

Read Pfizer press release